ModelEdge

Actinium Pharmaceuticals Inc.
ATNM
Filing TypeS-3
Filing Date8/6/2020
Updated8/7/20, 10:02 AM

Filing

S-3
Earnings Release

Exhibits

S-3Registration Statement for Securities Offered under a Shelf Registration
EX-1.2
EX-5.1OPINION OF HAYNES AND BOONE LLP
EX-23.1CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic